Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does MOXIFLOXACIN Cause Dermatitis exfoliative generalised? 14 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Dermatitis exfoliative generalised have been filed in association with MOXIFLOXACIN (Moxifloxacin Hydrochloride Tablets, 400 mg). This represents 0.1% of all adverse event reports for MOXIFLOXACIN.

14
Reports of Dermatitis exfoliative generalised with MOXIFLOXACIN
0.1%
of all MOXIFLOXACIN reports
1
Deaths
4
Hospitalizations

How Dangerous Is Dermatitis exfoliative generalised From MOXIFLOXACIN?

Of the 14 reports, 1 (7.1%) resulted in death, 4 (28.6%) required hospitalization.

Is Dermatitis exfoliative generalised Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for MOXIFLOXACIN. However, 14 reports have been filed with the FAERS database.

What Other Side Effects Does MOXIFLOXACIN Cause?

Drug hypersensitivity (2,013) Off label use (1,563) Dyspnoea (1,543) Drug ineffective (1,496) Vomiting (1,377) Pain (1,368) Asthma (1,342) Neuropathy peripheral (1,331) Rash (1,212) Pneumonia (1,172)

What Other Drugs Cause Dermatitis exfoliative generalised?

ALLOPURINOL (192) DUPILUMAB (162) METHOTREXATE (151) SULFAMETHOXAZOLE\TRIMETHOPRIM (140) AMOXICILLIN (122) ADALIMUMAB (113) PANTOPRAZOLE (105) SECUKINUMAB (96) VANCOMYCIN (92) AMLODIPINE (91)

Which MOXIFLOXACIN Alternatives Have Lower Dermatitis exfoliative generalised Risk?

MOXIFLOXACIN vs MOXIFLOXACIN\MOXIFLOXACIN MOXIFLOXACIN vs MOXONIDINE MOXIFLOXACIN vs MS CONTIN MOXIFLOXACIN vs MULTAQ MOXIFLOXACIN vs MULTIHANCE

Related Pages

MOXIFLOXACIN Full Profile All Dermatitis exfoliative generalised Reports All Drugs Causing Dermatitis exfoliative generalised MOXIFLOXACIN Demographics